Aptima Combo 2 Assay (250 test kit) Panther, Aptima Combo 2 Assay (250 test kit) Tigris, Aptima Trichomonas Vaginalis Assay (250 test kit) Panther, Aptima Trichomonas Vaginalis Assay (250 test kit) Tigris
Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections. 510(k) K220321, from Hologic, Inc. (San Diego, CA). Product code QEP, class 2.
As of Nov 22, 2026, K220321 is an FDA 510(k) held by Hologic, Inc., substantially equivalent on Jun 3, 2022 after 120 days, with no recalls tied to it in FDA's recall database.
- Review time: 120 days
- Recalls: 0
- Aptima Combo 2 Assay (Panther System), Aptima Combo 2 Assay (Tigris) System)K200866 · Hologic, Inc. · May 17, 2020
- Aptima Trichomonas Vaginalis Assay - PantherK122062 · Gen-Probe, Inc. · Jan 9, 2013
- K102911K102911
- cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systemsK260917 · Roche Molecular Systems, Inc. · Jul 8, 2026
- BD CTGCTV2K243343 · Bd Integrated Diagnostic Solutions/Becton, · Apr 22, 2025
- NeuMoDx CT/NG Assay 2.0K230267 · Neumodx Molecular, Inc. · Dec 22, 2023
- Alinity m STI AssayK222379 · Abbott Molecular, Inc. · Mar 3, 2023
- BD CTGCTV2K210585 · Becton, Dickinson and Company · May 10, 2022
- Alinity m STI AssayK202977 · Abbott Molecular, Inc. · Apr 29, 2022
- Rheonix STI TriPlex Assay, Rheonix EncompassMDx Workstation (instrument and software), Rheonix Urine Specimen…K193081 · Rheonix, Inc. · Dec 17, 2021
- cobas CTNG for use on cobas 6800/8800 systemsK202408 · Roche Molecular Systems, Inc. · Jan 21, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Feb 3, 2022
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3393
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files